Anzeige
Mehr »
Login
Mittwoch, 01.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
47 Leser
Artikel bewerten:
(0)

Unity Management Group, MCC Receives Authorization for Second Purchase Order From Bristol Meyers Squibb

EAST HANOVER, N.J., July 5, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) "UNITY" (or the "Company") (MCC) Metropolitan Computing Corporation has received authorization for a second purchase order to come in this week from Bristol Meyers Squibb, BMS Pharmaceuticals LTD., one of the largest pharmaceutical companies ,for $108,000.00 . MCC completed installation on the first order from Bristol Meyers Squibb UK, with successful results, using their complete instrumentation and calibration services to upgrade preexisting equipment with MCC's proprietary Advanced Instrumentation Monitor technology (AIM).

The MCC instrumentation monitoring system is engineered to integrate hardware and software into a complete data acquisition and analysis system. AIM is a state-of-the-art tool that facilitates research, process development, scale-up, and production of tablets and capsules. It is Windows NT based and provides continuous batch recordings and process optimization for all instrumented equipment. The system is modular and is contained in a mobile enclosure or laptop computer that can be moved between different types of instrumented equipment. Each system can be custom tailored to match customer specific needs.

"We continue to improve, and expand our company with this second order from BMS LTD," said Ron Berman President. "We are continuing to expand our range of development and becoming the leader in our industry. With the consolidation and streamlining of the entire major pharmaceutical companies today our abilities to upgrade existing equipment, to save time and expense has become very valuable."

About Bristol Meyers Squibb:

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers' needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs. The strategy is working. For the past three years, our total return for shareholders, including dividends, has been among the best in the industry. We outperformed most mega pharma companies, diversified companies and pure biotech companies. Reflecting our long-standing commitment to deliver shareholder value, our company has paid dividends to stockholders for more than 300 consecutive quarters.


Net Sales:

$19.5 billion in 2010

R&D Investment:

$3.6 billion in 2010

2010 Largest-Selling Products:

PLAVIX®, $6.7 billion

ABILIFY®, $2.6 billion

REYATAZ®, $1.5 billion

AVAPRO®/AVALIDE®, $1.2 billion

SUSTIVA® franchise, $1.4 billion

BARACLUDE®, $931 million




www.bms.com

About Unity Management Group, Inc.: Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPAA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physicians' offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company will be providing medical, vision and dental plans, as well as PPO and HMO networks.

For more information please go to our website which can be found at

www.unitymanagementgroup.com www.mcc-online.com

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company's inability to accurately forecast its operating results; the Company's potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company's business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

Unity Management Group, Inc. Investor Relations 855-413-0755

SOURCE Unity Management Group, Inc.

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.